Home » Newsletters » BioWorld Science

BioWorld Science

July 14, 2004

View Archived Issues

Studies highlight pimecrolimus efficacy in children with atopic dermatitis

New Glimicron presentation launched in Japan

McNeil and ICAgen enter agreement for ICA-17043 for sickle cell anemia

Grant for Alzheimer's diagnostic work at Samaritan and Georgetown University

Cytorex Biosciences completes cytotoxicity testing with Cytoreg

OPT-CHF phase II study of oxypurinol recommended to continue

NeuTec reports positive data for Mycograb

Adherex Technologies updates status of two key programs

GlaxoSmithKline and Biota hepatitis C collaboration to conclude

Copackage of Combivir and Viramune planned for developing world

Ortho-Clinical Diagnostics acquires rights to NT-proBNP by Roche Diagnostics

ZyComb shows efficacy and safety in phase III study

UCB offer for Celltech is successful

Fast track status for pixantrone in aggressive NHL

Pain Therapeutics' efforts in neuropathic pain supported by NIH grant

Pharmacokinetics of capravirine regimens assessed in healthy subjects

Studies reveal efficacy of tenofovir in HBV/HIV co-infected patients

Promising safety and pharmacokinetic profile of AMD-070 in healthy subjects

Long-term efficacy and safety of enfuvirtide in HIV-infected patients

Reverset shows antiviral efficacy in HIV-infected patients

Antibacterial oxazolidinones in development at Pfizer

Vertex claims protein kinase inhibitors

Aldosterone synthase inhibitors reported by Novartis

Fluorinated amides disclosed by Pfizer

Oxford GlycoSciences claims antiangiogenic agents

Multilayered tablet claimed by Bristol-Myers Squibb

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....